Abdul Chohan serves as Executive at GenMark Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Abdul Chohan has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 22, 2021 involved transacting 63,750 shares valued at $1.5M.
Abdul Chohan currently holds 63,750 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abdul Chohan has been a net neutral trader of GNMK stock. They have purchased $0 and sold $0 worth of shares.
Abdul Chohan's most recent insider trade was on Apr 22, 2021, when they sold 63,750 shares at $24.05 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |